REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Derostic Corp. CIA Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Derostic Corp. CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Derostic Corp. CIA Ltda is a company in Ecuador, with a head office in Cuenca. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on March 06, 2008. The total number of employees is currently 5 (2023). In its most recent financial highlights, the company reported a net sales revenue drop of 15.54% in 2023. There was a total growth of 27.16% in Derostic Corp. CIA Ltda’s total assets over the same period. In 2023, Derostic Corp. CIA Ltda’s net profit margin decreased by 6.39%.

Headquarters
del Eneldo
Cuenca; Azuay;

Contact Details: Purchase the Derostic Corp. CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Derostic Corp. CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Derostic Corp. CIA Ltda report to view the information.
Registered Capital:
Purchase the Derostic Corp. CIA Ltda report to view the information.
Incorporation Date:
March 06, 2008
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
48%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Derostic Corp. CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-15.54%▼
Total operating revenue
-15.54%▼
Operating profit (EBIT)
-74.25%▼
Net Profit (Loss) for the Period
-73.62%▼
Total assets
27.16%▲
Total equity
6.47%▲
Operating Profit Margin (ROS)
-9.98%▼
Net Profit Margin
-6.39%▼
Return on Equity (ROE)
-18.44%▼
Quick Ratio
0.07%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo